electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Rich Cockrell CG Capital404-736-3838 firstname.lastname@example.org or Media Contact: Summer DiazelectroCore 816-401-6333 email@example.com